Juno’s support of the Society of Hospital Pharmacists of Australia (SHPA) has today been strengthened, with the announcement of a new $30,000 research grant. The provision of this grant will provide up and coming Australian clinical pharmacists with an unprecedented opportunity to improve patient safety in the use of high-risk medicines.
The new research grant is yet another way in which Juno is seeking to collaborate with hospitals, hospital pharmacists and the professional organisation (SHPA) that represents them.
CEO and Managing Director of Juno, Mark Crotty, had this to say –
“Juno is looking forward to strengthening its support of SHPA through the $30,000 Emerging Researcher Grant. As an organisation, Juno embraces and encourages innovation and continuous improvement. Therefore, we are excited about the opportunity this provides to pharmacists and potential this research has to improve patient outcomes.”
CEO of SHPA, Kristin Michaels, says “SHPA and Juno are proud to join forces to support emerging researchers in their quest to improve the safe use of high-risk medicines.”
Perfect for emerging pharmacy researchers with previous proven experience, the Emerging Researcher Grant provides a “next step” towards supporting future, larger research projects while funding initiatives that directly improve patient safety in current practice.
The new grant, available through SHPA’s National Translational Research Collaborative (NTRC) has almost doubled their pool of funding available to date. Evaluation of research projects will be an independent process, conducted by the NTRC Research Grants Committee.
For more information on the grant, including application criteria, key dates and a link to submit expressions of interest, visit www.shpa.org.au/juno-grant

About SHPA
The Society of Hospital Pharmacists of Australia (SHPA) is the national, professional, for-purpose organisation for leading pharmacists and pharmacy technicians working across Australia’s health system, advocating for their pivotal role improving the safety and quality of medicines use. Embedded in multidisciplinary medical teams and equipped with exceptional medicines management expertise, SHPA members are progressive advocates for clinical excellence, committed to evidence-based practice and passionate about patient care. For more information on SHPA, visit www.shpa.org.au/

About The NTRC
The NTRC is a virtual hub connecting Australia’s brightest clinical pharmacy researchers to build capacity and inter-hospital partnerships, strengthen proposals and impact, and leverage funding opportunities. The NTRC helps turn more pharmacists into pharmacy researchers, an advancement that furthers the workforce as a whole, ensuring the development and introduction of new and improved clinical services. For more information on the NTRC, www.shpa.org.au/ntrc

Med202. Prepared July 2018.